Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer

Bayne, Lauren J., Beatty, Gregory L., Jhala, Nirag, Clark, Carolyn E., Rhim, Andrew D., Stanger, Ben Z., Vonderheide, Robert H.·2012·Cancer Cell

Cited by (952)

Items 301–400 of 952

  1. GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity
    Luis I. Ruffolo, Katherine M. Jackson, Peyton C. Kuhlers, Benjamin S. Dale, Nathania Figueroa-Guilliani, Nicholas A. Ullman, Paul R. Burchard, Shuyang Qin, Peter G. Juviler, Jessica Millian Keilson et al. · 2021 · Gut
  2. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer
    Jian Ye, Bradley N. Mills, Shuyang Qin, Jesse Garrett-Larsen, Joseph D. Murphy, Taylor Paige Uccello, Booyeon Julia Han, Tara G Vrooman, Carl J. Johnston, Edith M. Lord et al. · 2022 · Journal for ImmunoTherapy of Cancer
  3. Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma
    Maria Victoria Recouvreux, Shea F. Grenier, Yijuan Zhang, Edgar Esparza, Guillem Lambies, Cheska Marie Galapate, Swetha Maganti, Karen Duong‐Polk, Deepika Bhullar, Razia F. Naeem et al. · 2023 · Nature Cancer
  4. Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs
    Buqing Sai, Yafei Dai, Songqing Fan, Fan Wang, Lujuan Wang, Zheng Li, Jingqun Tang, Li Wang, Xina Zhang, Leliang Zheng et al. · 2019 · Cell Death and Disease
  5. GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency
    Ping Ye, Wenhao Chen, Jie Wu, Xiaofan Huang, Jun Li, Sihua Wang, Zheng Liu, Guohua Wang, Xiao Yi Yang, Peng Zhang et al. · 2013 · Journal of Clinical Investigation
  6. Exploiting inflammation for therapeutic gain in pancreatic cancer
    Colin William Steele, Nigel Balfour Jamieson, T.R.J. Evans, C. J. McKay, Owen James Sansom, Jennifer P. Morton, C R Carter · 2013 · British Journal of Cancer
  7. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
    Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, Laura Soucek · 2024 · Signal Transduction and Targeted Therapy
  8. Immunosuppressive CD14 + HLA-DR lo/neg monocytes are elevated in pancreatic cancer and “primed” by tumor-derived exosomes
    Naureen Javeed, Michael P. Gustafson, Shamit Kumar Dutta, Yi Lin, William R. Bamlet, Ann L. Oberg, Gloria M. Petersen, Suresh T. Chari, Allan B. Dietz, Debabrata Mukhopadhyay · 2016 · OncoImmunology
  9. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
    Xingyi Pan, Lei Zheng · 2020 · Cellular and Molecular Immunology
  10. Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects
    Salvatore Cortellino, Alessandro Raveane, Claudia Chiodoni, Gloria Delfanti, Federica Pisati, V. Spagnolo, Euplio Visco, Giuseppe Fragale, Federica Ferrante, Serena Magni et al. · 2022 · Cell Reports
  11. Protectin DX, a Double Lipoxygenase Product of DHA, Inhibits Both ROS Production in Human Neutrophils and Cyclooxygenase Activities
    Miao Liu, Tarek Boussetta, Karama Makni‐Maalej, Michèle Fay, Fathi Driss, Jamel El Benna, Michel Lagarde, Michel Guichardant · 2013 · Lipids
  12. Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease
    Jack Hutcheson, Uthra Balaji, Matthew R. Porembka, Megan Wachsmann, Peter A. McCue, Erik S. Knudsen, Agnieszka Katarzyna Witkiewicz · 2016 · Clinical Cancer Research
  13. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma
    Jing Zhang, Xiongfei Xu, Min Shi, Ying Chen, Danghui Yu, Chenyan Zhao, Yan Gu, Biao Yang, Shiwei Guo, Guiling Ding et al. · 2017 · OncoImmunology
  14. Molecular Regulation of Bone Metastasis Pathogenesis
    Meng‐Yu Wu, Chia‐Jung Li, Giou‐Teng Yiang, Yeung‐Leung Cheng, Andy Po‐Yi Tsai, Yueh-Tseng Hou, Yu-Chieh Ho, Ming‐Feng Hou, Pei‐Yi Chu · 2018 · Cellular Physiology and Biochemistry
  15. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ
    Yi Liu, Yasunori Deguchi, Daoyan Wei, Fuyao Liu, Micheline J. Moussalli, Eriko Deguchi, Donghui Li, Huamin Wang, Lovie Ann Valentin, Jennifer K. Colby et al. · 2022 · Nature Communications
  16. β-Catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8+ T cells
    Xinjun Liang, Chunmei Fu, Weiguo Cui, Julia L. Ober-Blöbaum, Sonja Petra Zahner, Protul A. Shrikant, Björn E. Clausen, Richard Anthony Flavell, Ira Mellman, Aimin Jiang · 2013 · Journal of Leukocyte Biology
  17. Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy
    Bradley N. Mills, Haoming Qiu, Michael G. Drage, Chunmo Chen, Jocelyn S. Mathew, Jesse Garrett-Larsen, Jian Ye, Taylor Paige Uccello, Joseph D. Murphy, Brian A. Belt et al. · 2021 · Clinical Cancer Research
  18. Molecular mechanisms regulating secretory organelles and endosomes in neutrophils and their implications for inflammation
    Mahalakshmi Ramadass, Sergio Daniel Catz · 2016 · Immunological Reviews
  19. Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro
    Haifang Wang, Fen Ning, Zongcai Liu, Long Wu, Zi-Qian Li, Yi-Fei Qi, Ge Zhang, Hongsheng Wang, Shaohui Cai, Jun Du · 2016 · Cancer Immunology Immunotherapy
  20. The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting
    Nicolas Jonckheere, Romain Vasseur, Isabelle VAN SEUNINGEN · 2017 · Critical Reviews in Oncology/Hematology
  21. Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer
    Jennifer Brooks, Bettina Fleischmann-Mundt, Norman Woller, Julia Niemann, Silvia Ribback, Kristin Peters, İhsan Ekin Demir, Nina Armbrecht, Guralp Onur Ceyhan, Michael Peter Manns et al. · 2017 · Cancer Research
  22. The Engagement Between MDSCs and Metastases: Partners in Crime
    Rosalinda Trovato, Stefania Canè, Varvara Petrova, Silvia Sartoris, Stefano Ugel, Francesco De Sanctis · 2020 · Frontiers in Oncology
  23. Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels
    Bo Kong, Chengjia Qia, Mert Erkan, Jorg H. Kleeff, Christoph W. Michalski · 2013 · Frontiers in Physiology
  24. Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic
    Emmanouil Fokas, Eric O’Neill, Alex Nicolas Gordon-Weeks, Somnath Mukherjee, W. Gillies McKenna, Ruth J. Muschel · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  25. The pancreatic cancer microenvironment: A true double agent
    Laleh Golkar Melstrom, Marcela d'Alincourt Salazar, Don J. Diamond · 2017 · Journal of Surgical Oncology
  26. Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis
    Howard C. Crawford, Marina Pasca di Magliano, Sulagna Banerjee · 2019 · Gastroenterology
  27. SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer
    Gregory P. Botta, Shumei Kato, Hitendra Patel, Paul Timothy Fanta, Suzanna Lee, Ryosuke Okamura, Razelle Kurzrock · 2021 · JCI Insight
  28. Cancer-Associated Myeloid Regulatory Cells
    Yannick De Vlaeminck, Anna Arely González-Rascón, Cleo Goyvaerts, Karine Breckpot · 2016 · Frontiers in Immunology
  29. Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
    Kate Young, Daniel Johnathan Hughes, David Cunningham, Naureen Starling · 2018 · Therapeutic Advances in Medical Oncology
  30. Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21
    Xuan Lin, Long‐Yun Ye, Xu Wang, Zhenyu Liao, Jia Dong, Ying Yang, Rulin Zhang, Hao Li, Pengcheng Li, Lei Ding et al. · 2021 · Cancers
  31. Pancreatic cancer-associated stellate cells
    Thomas A. Mace, Mark Bloomston, Gregory B. Lesinski · 2013 · OncoImmunology
  32. T-cell–Secreted TNFα Induces Emergency Myelopoiesis and Myeloid-Derived Suppressor Cell Differentiation in Cancer
    Mohamad F. Al Sayed, Michael A. Amrein, Elias D. Bührer, Anne-Laure Huguenin, Ramin Radpour, Carsten Riether, Adrian F. Ochsenbein · 2018 · Cancer Research
  33. Genetics and Biology of Pancreatic Ductal Adenocarcinoma
    Richard Francis Dunne, Aram F. Hezel · 2015 · Hematology/Oncology Clinics of North America
  34. Tumor Cell–Intrinsic USP22 Suppresses Antitumor Immunity in Pancreatic Cancer
    Jinyang Li, Salina Yuan, Robert J. Norgard, Fangxue Yan, Taiji Yamazoe, Mario Andres Blanco, Ben Z. Stanger · 2019 · Cancer Immunology Research
  35. Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity
    Bhalchandra Mirlekar, Yan Wang, Sirui Li, Mi Zhou, Sarah Entwistle, Tristan De Buysscher, Ashley B. Morrison, Gabriela Herrera, Cameron Harris, Benjamin Garrett Vincent et al. · 2022 · Cell Reports Medicine
  36. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect
    Dinesh Chandra, Benson Chellakkan Selvanesan, Ziqiang Yuan, Steven K. Libutti, Wade R. Koba, Amanda P. Beck, Kun Zhu, Arturo Casadevall, Ekaterina Dadachova, Claudia Gravekamp · 2017 · Oncotarget
  37. Tumor-Derived GM-CSF Promotes Inflammatory Colon Carcinogenesis via Stimulating Epithelial Release of VEGF
    Yi Wang, Gencheng Han, Ke Wang, Guijun Liu, Renxi Wang, Xiao He, Xinying Li, Chunmei Hou, Beifen Shen, Renfeng Guo et al. · 2013 · Cancer Research
  38. Tumour‐induced immune suppression: role of inflammatory mediators released by myelomonocytic cells
    Yumeng Mao, Isabel C. Poschke, Rolf W. Kiessling · 2014 · Journal of Internal Medicine
  39. Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”
    Robert Hester, Pawel Karol Mazur, Florencia McAllister · 2021 · Clinical Cancer Research
  40. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis
    Ryan J. King, Surendra Kumar Shukla, Chunbo He, Enza Vernucci, Ravi Thakur, Kuldeep Singh Attri, Aneesha Dasgupta, Nina V. Chaika, Scott E. Mulder, Jaime Abrego et al. · 2022 · Oncogene
  41. Cancer immune exclusion: breaking the barricade for a successful immunotherapy
    Sofía Bruni, Maria Florencia Mercogliano, Florencia Luciana Mauro, Rosalía I. Cordo Russo, Roxana Schillaci · 2023 · Frontiers in Oncology
  42. The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
    Heng‐Chung Kung, Kevin Zheng, Jacquelyn W. Zimmerman, Lei Zheng · 2025 · Nature Reviews Clinical Oncology
  43. Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype
    Simone Borgoni, Andrea Iannello, Santina Cutrupi, Paola Allavena, Maurizio D’Incalci, Francesco Novelli, Paola Cappello · 2017 · OncoImmunology
  44. Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment
    Javed Mahmood, Hem Dutt Shukla, Sandrine Soman, Santanu Samanta, Prerna Singh, Shriya Kamlapurkar, Ali M. Saeed, Neha P. Amin, Željko Vujašković · 2018 · Cancers
  45. Chronic restraint stress promotes hepatocellular carcinoma growth by mobilizing splenic myeloid cells through activating β-adrenergic signaling
    Wei Jiang, Li Yu, Zhenzhen Li, Jin Sun, Jiang-wei Li, Wei Wei, Liang Li, Chen Zhang, Chen Huang, Shuanying Yang et al. · 2019 · Brain Behavior and Immunity
  46. IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer
    Bhalchandra Mirlekar, Daniel E. Michaud, Ryan Searcy, Kevin Greene, Yuliya Pylayeva‐Gupta · 2018 · Cancer Immunology Research
  47. Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes
    Dmitry V. Chouljenko, Jun Ding, I‐Fang Lee, Yanal M. Murad, Xuexian Bu, Guoyu Liu, Zahid M. Delwar, Yi Sun, Sheng Yu, Ismael J. Samudio et al. · 2020 · Biomedicines
  48. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
    Cameron J. Herting, Isaac Karpovsky, Gregory B. Lesinski · 2021 · Cancer and Metastasis Reviews
  49. Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
    Michela Cortesi, Michele Zanoni, Francesca Pirini, Maria Maddalena Tumedei, Sara Ravaioli, Ilario Giovanni Rapposelli, Giovanni Luca Frassineti, Sara Bravaccini · 2021 · International Journal of Molecular Sciences
  50. Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
    Anne-Laure Désage, Camille Léonce, Aurélie Swalduz, Sandra Ortiz‐Cuaran · 2022 · Frontiers in Oncology
  51. Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance
    Abakundana Nsenga Ariston Gabriel, Qinlian Jiao, Yvette Umwali, Xuemei Yang, Samed Ahmed Al-Ezzi Al-Ameri, Lutao Du, Yunshan Wang, Chuanxin Wang · 2019 · Pancreatology
  52. A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
    Tamas A. Gonda, Jarwei Fang, Martha C. Salas, Catherine Do, Emily Hsu, Anna Zhukovskaya, Ariel Siegel, Ryota Takahashi, Zoila Areli Lopez Bujanda, Charles G. Drake et al. · 2020 · Cancer Research
  53. Neutrophils at the Crossroads: Unraveling the Multifaceted Role in the Tumor Microenvironment
    Deepika Awasthi, Aditya Yashwant Sarode · 2024 · International Journal of Molecular Sciences
  54. Dendritic cell immunotherapy
    Rachel Lubong Sabado, Nina Bhardwaj · 2013 · Annals of the New York Academy of Sciences
  55. SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells
    Hao Yu, Yudong Liu, Braden C. McFarland, Jessy S. Deshane, Douglas R. Hurst, Selvarangan Ponnazhagan, Etty N. Benveniste, Hongwei Qin · 2015 · Cancer Immunology Research
  56. Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations
    Kiah L. Sanders, Barbara A. Fox, David J. Bzik · 2015 · Cancer Immunology Research
  57. Tracking cells in their native habitat: lineage tracing in epithelial neoplasia
    Maria Pilar Alcolea, Philip H. Jones · 2013 · Nature reviews. Cancer
  58. Cancer cell CCR2 orchestrates suppression of the adaptive immune response
    Miriam R. Fein, Xue‐Yan He, Ana Santos Almeida, Emilis Bružas, Arnaud Pommier, Ran Yan, Anaïs Eberhardt, Douglas T. Fearon, Linda Van Aelst, John Erby Wilkinson et al. · 2020 · The Journal of Experimental Medicine
  59. Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF-PI3K pathway
    Boyer, Seth, Lee, Ho-Joon, Steele, Nina, Zhang, Li, Sajjakulnukit, Peter, Andren, Anthony, Ward, Matthew H, Singh, Rima, Basrur, Venkatesha, Zhang, Yaqing et al. · 2022 · eLife
  60. Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer
    Samantha B. Kemp, Marina Pasca di Magliano, Howard C. Crawford · 2021 · Cellular and Molecular Gastroenterology and Hepatology
  61. Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
    Shivan Sivakumar, Enas Abu‐Shah, David Ahern, Edward H. Arbe-Barnes, Ashwin Jainarayanan, Nagina Mangal, Srikanth Reddy, Aniko Rendek, Alistair Easton, Elke Kurz et al. · 2021 · Cancers
  62. T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma
    Margo Orlen, William P. Vostrejs, Rina Sor, Jayne C. McDevitt, Samantha B. Kemp, Il‐Kyu Kim, Adam B. Kramer, Nataliya Tovbis Shifrin, Nune Markosyan, Cynthia Clendenin et al. · 2025 · Cancer Discovery
  63. Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study
    Daniela Basso, Paola Fogar, Massimo Falconi, Elisa Fadi, Cosimo Sperti, Chiara Frasson, Eliana Greco, Domenico Tamburrino, Sara Teolato, Stefania Moz et al. · 2013 · PLoS ONE
  64. The Impact of the Myeloid Response to Radiation Therapy
    M. Gough, K. Young, M. Crittenden · 2013 · Clinical and Developmental Immunology
  65. Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
    Songchuan Guo, Merly Contratto, George Miller, Lawrence Leichman, Jennifer J. Wu · 2017 · World Journal of Clinical Oncology
  66. Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy
    Chunyu Xia, Man Li, Guang‐Yao Ran, Xuhui Wang, Zhengze Lu, Ting Li, Xian Tang, Zhirong Zhang, Qin He · 2021 · Journal of Controlled Release
  67. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer
    Kabashima, Ayano, Matsuo, Yuki, Ito, Saki, Akiyama, Yoshimitsu, Ishii, Takeshi, Shimada, Shu, Masamune, Atsushi, Tanabe, Minoru, Tanaka, Shinji · 2022 · Scientific Reports
  68. Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy
    Sumanta Kumar Pal, Dayson Moreira, Haejung Won, Seok Voon White, Pryanka Duttagupta, Marc Lúcia, Jeremy O. Jones, Joann Hsu, Marcin Kortylewski · 2019 · International Journal of Molecular Sciences
  69. Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
    Young-Jun Park, Boyeong Song, Yun-Sun Kim, Eun‐Kyung Kim, Jung-Mi Lee, Ga-Eun Lee, Jae‐Ouk Kim, Yeon‐Jeong Kim, Woo‐Sung Chang, Chang‐Yuil Kang · 2013 · Cancer Research
  70. Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages
    Sushil Kumar K, María P. Torres, Sukhwinder Kaur, Satyanarayana Rachagani, Suhasini Joshi, Sonny L. Johansson, Navneet Momi, Michael J. Baine, Christine E Gilling, Lynette M. Smith et al. · 2014 · Oncogene
  71. Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle
    Max Miller Wattenberg, Gregory Lawrence Beatty · 2020 · Seminars in Cancer Biology
  72. Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment
    Qiaofei Liu, Huanwen Wu, Yuan Li, Ronghua Zhang, Jorg H. Kleeff, Xiang Zhang, Ming Cui, Jingkai Liu, Tong Li, Junyi Gao et al. · 2020 · Cancer Immunology Immunotherapy
  73. Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells
    Ainhoa Arina, Vincenzo Bronte · 2015 · Current Opinion in Immunology
  74. Inhibiting PI3 kinase-γ in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors
    Xueqiong Zhang, Limei Shen, Qi Liu, Lin Hou, Leaf Huang · 2019 · Journal of Controlled Release
  75. Immune cellular components and signaling pathways in the tumor microenvironment
    Sasitorn Yenyuwadee, Konstantinos Aliazis, Qi Wang, Anthos Christofides, Rushil Shah, Nikolaos Patsoukis, Vassiliki A. Boussiotis · 2022 · Seminars in Cancer Biology
  76. Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma
    Jing Liu, Wenna Jiang, Kaili Zhao, Hongwei Wang, Tianxing Zhou, Weiwei Bai, Xiuchao Wang, Tiansuo Zhao, Chongbiao Huang, Song Gao et al. · 2019 · The Journal of Experimental Medicine
  77. Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
    Zoe C. Schmiechen, Ingunn M. Stromnes · 2021 · Frontiers in Immunology
  78. Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment
    Rakesh Bhatia, Namita Bhyravbhatla, Andrew Kisling, Xiaoqi Li, Surinder K. Batra, Sushil Kumar K · 2022 · Seminars in Cancer Biology
  79. IFN Regulatory Factor 8 Represses GM-CSF Expression in T Cells To Affect Myeloid Cell Lineage Differentiation
    Amy V. Paschall, Ruihua Zhang, Chen‐Feng Qi, Kankana Bardhan, Liang Peng, Geming Lu, Jianjun Yang, Miriam Mérad, Tracy L. McGaha, Gang Zhou et al. · 2015 · The Journal of Immunology
  80. Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy
    Robert J. Torphy, Richard David Schulick, Yuwen Zhu · 2020 · Molecular Carcinogenesis
  81. Chronic Pancreatitis and the Development of Pancreatic Cancer
    Hemanth Kumar Kandikattu, Sathisha Upparahalli Venkateshaiah, Anil Mishra · 2020 · Endocrine Metabolic & Immune Disorders - Drug Targets
  82. Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
    Thomas Yul Avery, Natalie Köhler, Robert Zeiser, Tilman Brummer, Dietrich Alexander Ruess · 2022 · Frontiers in Oncology
  83. Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
    Daiyong Deng, Riya H. Patel, Cheng-Yao Chiang, Pingping Hou · 2022 · Cells
  84. Circulating myeloid-derived suppressor cells in patients with pancreatic cancer
    Xiaodong Xu, Jun Hu, Min Wang, Feng Peng, Rui Tian, Xingjun Guo, Yu Xie, Renyi Qin · 2016 · Hepatobiliary & pancreatic diseases international
  85. How Tumor Cell Dedifferentiation Drives Immune Evasion and Resistance to Immunotherapy
    Jinyang Li, Ben Z. Stanger · 2020 · Cancer Research
  86. Mechanosensitive Ion Channels and Their Role in Cancer Cells
    Julia Karska, Szymon Kowalski, Jolanta Saczko, Mihaela Georgeta Moisescu, Julita Kulbacka · 2023 · Membranes
  87. Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies
    Anna Linehan, Mary O’Reilly, Ray McDermott, Grainne Mary O'Kane · 2024 · Frontiers in Medicine
  88. Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer
    Yijuan Zhang, Ling Li, Rabi Murad, Swetha Maganti, Ambroise Manceau, Hannah A. Faso, Madelaine Neff, Cheska Marie Galapate, Shea F. Grenier, Florent Carrette et al. · 2025 · Cancer Cell
  89. Epithelial-Stromal Interactions in Pancreatic Cancer
    Yaqing Zhang, Howard C. Crawford, Marina Pasca di Magliano · 2018 · Annual Review of Physiology
  90. Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
    Robert H. Vonderheide, Adham Sean Bear · 2020 · Frontiers in Immunology
  91. Tumor-Specific CD4 T Cells Instruct Monocyte Differentiation in Pancreatic Ductal Adenocarcinoma
    Michael T. Patterson, Adam L. Burrack, Yingzheng Xu, Grant H. Hickok, Zoe C. Schmiechen, Samuel Becker, Eduardo Cruz-Hinojoza, Patricia R. Schrank, Ainsley E. Kennedy, Maria M. Firulyova et al. · 2022 · Cell Reports
  92. Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells
    Dominique Santos Rubenich, Natália Omizzollo, Mirosław J. Szczepański, Torsten E. Reichert, Theresa L. Whiteside, Nils Ludwig, Elizandra Braganhol · 2021 · Cytokine & Growth Factor Reviews
  93. Role of the β Common (βc) Family of Cytokines in Health and Disease
    Timothy R. Hercus, Winnie L. Kan, Sophie E. Broughton, Denis Tvorogov, Hayley S. Ramshaw, Jarrod John Sandow, Tracy L. Nero, Urmi Dhagat, Emma J. Thompson, Karen S. Cheung Tung Shing et al. · 2017 · Cold Spring Harbor Perspectives in Biology
  94. Neutrophils as Orchestrators in Tumor Development and Metastasis Formation
    Lydia Kalafati, Ioannis Mitroulis, Panayotis Verginis, Triantafyllos Chavakis, Ioannis Kourtzelis · 2020 · Frontiers in Oncology
  95. Targeting immunosuppression for cancer therapy
    Cristina Ghirelli, Thorsten Hagemann · 2013 · Journal of Clinical Investigation
  96. Myeloid-derived suppressor cells and T regulatory cells in tumors: unraveling the dark side of the force
    Aikaterini Hatzioannou, Themis Alissafi, Panayotis Verginis · 2017 · Journal of Leukocyte Biology
  97. Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells
    Michael W. Pickup, Philip Owens, Agnieszka E. Gorska, Anna M. Chytil, Fei Ye, Chanjuan Shi, Valerie Marie Weaver, Raghu Kalluri, Harold L. Moses, Sergey V. Novitskiy · 2017 · Cancer Immunology Research
  98. A myeloid and lymphoid infiltrate in murine pancreatic tumors exposed to plasma-treated medium
    Kim Rouven Liedtke, Eric Freund, Christine Hackbarth, Claus-Dieter Heidecke, Lars-Ivo Partecke, Sander Bekeschus · 2018 · Clinical Plasma Medicine
  99. Prolactin promotes fibrosis and pancreatic cancer progression
    Manuj Tandon, Gina M. Coudriet, Angela Criscimanna, Mairobys Socorro, M. Eliliwi, A. Singhi, Z. Cruz-Monserrate, P. Bailey, M. Lotze, H. Zeh et al. · 2019 · Cancer Research
  100. The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation
    Xuebing Jia, Jianbei Xi, Binle Tian, Yuanyuan Zhang, Zhilong Wang, Fan Wang, Zheng Li, Jiang Long, JianFei Wang, Guo-Huang Fan et al. · 2023 · Cancer Immunology Research